COVID-19 (Coronavirus)

Small Bowel Diseases & Nutrition Clinical Trials

As a patient at Cedars-Sinai, you will have access to the latest clinical trials and research for small bowel disease and nutrition. Backed by a respected team of specialists and researchers, our clinical trials aim to further the advancement of diagnosing and treating your small bowel condition.

Questions? See the Clinical Trials FAQs.


Short bowel syndrome

Participant Requirements:

  • Diagnosis of SBS
  • Patients who have never received teduglutide treatment must be on parenteral nutrition/IV support for at least 6 months


The purpose of this registry study is to evaluate safety and clinical outcomes in patients with short bowel syndrome (SBS). The study aims to determine whether patients who take teduglutide (a medication for short bowel syndrome) are at a higher risk of developing colon cancer than those who do not take teduglutide.